Our newest Innovation Challenge in IBD - Share Far and Wide!
Here's the deets on our newest innovation challenge!
The goal of the 2022 Global Innovation Challenge: Addressing Unmet needs in IBD is to identify a wide range of innovative ideas and scalable solutions for better disease management and care. Unmet needs continue to afflict the everyday lives of IBD patients and their loved ones; we are seeking to change that, ultimately to improve outcomes and experiences for people affected by the disease.
The challenge is currently accepting applications through October 25, 2022. Selected applicants will be shortlisted as finalists and will receive an invitation to pitch their ideas and business solutions over the course of a two-day summit at Bristol Myers Squibb’s headquarters in New York City. An expert panel of judges comprised of healthcare industry, medical, and patient leaders will assess the innovators. Prizes will be awarded to two finalists to further grow their companies. The Innovation Award will be presented to a for-profit company and includes $25,000. The Impact Award will be presented to a not-for-profit company and includes $25,000.
This is a great opportunity for entrepreneurs in the IBD space, you can find the link here.
Those living with inflammatory bowel disease (IBD) face challenges just going through their regular, day to day life– but making things better is possible. Lyfebulb is currently accepting applications for the Global 2022 Innovation Challenge, in Collaboration with Bristol Myers Squibb, to Address Unmet Needs in Inflammatory Bowel Disease. This is a call-to-action for innovators with solutions to improve lives and outcomes for patients living with Crohn’s disease and ulcerative colitis. Two monetary prizes will be awarded totaling $50,000.
Submit your application before October 25th.
To learn more about the Challenge, click the link to apply.